Shanghai - Delayed Quote CNY

Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS)

14.83 +0.15 (+1.02%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Advanced Chart
Loading Chart for 688317.SS
DELL
  • Previous Close 14.68
  • Open 14.61
  • Bid 14.82 x --
  • Ask 14.83 x --
  • Day's Range 14.54 - 14.86
  • 52 Week Range 12.58 - 28.32
  • Volume 976,082
  • Avg. Volume 1,683,354
  • Market Cap (intraday) 2.887B
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) --
  • EPS (TTM) -0.71
  • Earnings Date --
  • Forward Dividend & Yield 1.20 (8.09%)
  • Ex-Dividend Date Jun 14, 2023
  • 1y Target Est --

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular genetic diagnostic reagents, instruments, and equipment in China. The company was founded in 2005 and is based in Shanghai, China.

www.liferiver.com.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Shanghai ZJ Bio-Tech Co., Ltd.

Related News

View More
View More

Performance Overview: 688317.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

688317.SS
29.31%
SSE Composite Index
3.82%

1-Year Return

688317.SS
46.04%
SSE Composite Index
5.40%

3-Year Return

688317.SS
77.15%
SSE Composite Index
11.10%

5-Year Return

688317.SS
--
SSE Composite Index
14.11%

Compare To: 688317.SS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

688317.SS
Shanghai ZJ Bio-Tech Co., Ltd.
14.83
+1.02%
Mkt Cap CNY 2.887B
Industry Medical Devices
4736.TW
TaiDoc Technology Corporation
154.00
-0.65%
Mkt Cap TWD 14.688B
Industry Medical Devices

Statistics: 688317.SS

View More

Valuation Measures

Annual
As of 4/27/2024

  • Market Cap

    2.89B

  • Enterprise Value

    125.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.42

  • Price/Book (mrq)

    0.75

  • Enterprise Value/Revenue

    0.46

  • Enterprise Value/EBITDA

    -1.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.25%

  • Return on Assets (ttm)

    -0.64%

  • Return on Equity (ttm)

    -3.16%

  • Revenue (ttm)

    274.32M

  • Net Income Avi to Common (ttm)

    -129.61M

  • Diluted EPS (ttm)

    -0.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.76B

  • Total Debt/Equity (mrq)

    0.15%

  • Levered Free Cash Flow (ttm)

    36.13M

View More

Company Insights: 688317.SS

People Also Watch

688298.SS Zhejiang Orient Gene Biotech Co.,Ltd
27.76
+1.87%
 
688289.SS Sansure Biotech Inc.
19.07
+1.44%
 
688068.SS Beijing Hotgen Biotech Co., Ltd.
28.44
+1.68%
 
688399.SS Jiangsu Bioperfectus Technologies Co., Ltd.
68.45
+1.56%
 
603882.SS Guangzhou Kingmed Diagnostics Group Co., Ltd.
38.10
-9.61%
 
688767.SS Hangzhou Biotest Biotech Co.,Ltd.
25.41
+0.87%
 
002030.SZ Daan Gene Co., Ltd.
7.47
+0.81%
 
603301.SS Zhende Medical Co., Ltd.
20.62
+0.10%
 
002932.SZ Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
19.59
-1.61%
 
688016.SS Shanghai MicroPort Endovascular MedTech Co., Ltd.
174.88
-3.12%
 
603658.SS Autobio Diagnostics Co., Ltd.
56.35
+0.21%
 
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
53.40
+4.38%
 
688301.SS iRay Technology Company Limited
192.86
-2.50%
 
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
68.26
+7.67%
 
603087.SS Gan & Lee Pharmaceuticals.
48.77
+1.60%
 
688139.SS Qingdao Haier Biomedical Co.,Ltd
36.93
+7.17%